{
    "xml": "<topic id=\"PHP78029\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/fragmin-single-dose-syringes\" basename=\"fragmin-single-dose-syringes\" title=\"Fragmin single-dose syringes\">\n<title>Fragmin<tm tmtype=\"reg\"/> single-dose syringes</title>\n<topic id=\"PHP59719\" outputclass=\"indicationsAndDose\" rev=\"1.37\" parent=\"/clinical-medicinal-product-information/fragmin-single-dose-syringes\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of deep-vein thrombosis in surgical patients&#8212;moderate risk</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 2500&#8239;units for 1 dose, dose to be given 1&#8211;2 hours before surgery, then 2500&#8239;units every 24&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of deep-vein thrombosis in surgical patients&#8212;high risk</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 2500&#8239;units for 1 dose, dose to be administered 1&#8211;2 hours before surgery, followed by 2500&#8239;units after 8&#8211;12&#8239;hours, then 5000&#8239;units every 24&#8239;hours, alternatively initially 5000&#8239;units for 1 dose, dose to be given on the evening before surgery, followed by 5000&#8239;units after 24&#8239;hours, then 5000&#8239;units every 24&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of deep-vein thrombosis in medical patients</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5000&#8239;units every 24&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of deep-vein thrombosis, with oral anticoagulant treatment</p>\n<p outputclass=\"therapeuticIndication\">Treatment of pulmonary embolism, with oral anticoagulant treatment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 45 kg)</p>\n<p>7500&#8239;units daily until adequate oral anticoagulation established.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 46&#8211;56 kg)</p>\n<p>10&#8239;000&#8239;units daily until adequate oral anticoagulation established.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 57&#8211;68 kg)</p>\n<p>12&#8239;500&#8239;units daily until adequate oral anticoagulation established.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 69&#8211;82 kg)</p>\n<p>15&#8239;000&#8239;units daily until adequate oral anticoagulation established.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 83 kg and above)</p>\n<p>18&#8239;000&#8239;units daily until adequate oral anticoagulation established.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Extended treatment and prophylaxis of venous thromboembolism in patients with solid tumours</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 40&#8211;45 kg)</p>\n<p>7500&#8239;units once daily for 30 days, then 7500&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 46&#8211;56 kg)</p>\n<p>10&#8239;000&#8239;units once daily for 30 days, then 7500&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 57&#8211;68 kg)</p>\n<p>12&#8239;500&#8239;units once daily for 30 days, then 10&#8239;000&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 69&#8211;82 kg)</p>\n<p>15&#8239;000&#8239;units once daily for 30 days, then 12&#8239;500&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 83&#8211;98 kg)</p>\n<p>18&#8239;000&#8239;units once daily for 30 days, then 15&#8239;000&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 99 kg and above)</p>\n<p>18&#8239;000&#8239;units once daily for 30 days, then 18&#8239;000&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of venous thromboembolism in pregnancy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 49 kg)</p>\n<p>5000&#8239;units twice daily, use body-weight in early pregnancy to calculate the dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 50&#8211;69 kg)</p>\n<p>6000&#8239;units twice daily, use body-weight in early pregnancy to calculate the dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 70&#8211;89 kg)</p>\n<p>8000&#8239;units twice daily, use body-weight in early pregnancy to calculate the dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 90 kg and above)</p>\n<p>10&#8239;000&#8239;units twice daily, use body-weight in early pregnancy to calculate the dose.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP78029",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/fragmin-single-dose-syringes",
    "basename": "fragmin-single-dose-syringes",
    "title": "Fragmin single-dose syringes",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of deep-vein thrombosis in surgical patients&#8212;moderate risk",
                        "html": "Prophylaxis of deep-vein thrombosis in surgical patients&#8212;moderate risk"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 2500 units for 1 dose, dose to be given 1&#8211;2 hours before surgery, then 2500 units every 24 hours.",
                        "html": "<p>Initially 2500&#8239;units for 1 dose, dose to be given 1&#8211;2 hours before surgery, then 2500&#8239;units every 24&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of deep-vein thrombosis in surgical patients&#8212;high risk",
                        "html": "Prophylaxis of deep-vein thrombosis in surgical patients&#8212;high risk"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 2500 units for 1 dose, dose to be administered 1&#8211;2 hours before surgery, followed by 2500 units after 8&#8211;12 hours, then 5000 units every 24 hours, alternatively initially 5000 units for 1 dose, dose to be given on the evening before surgery, followed by 5000 units after 24 hours, then 5000 units every 24 hours.",
                        "html": "<p>Initially 2500&#8239;units for 1 dose, dose to be administered 1&#8211;2 hours before surgery, followed by 2500&#8239;units after 8&#8211;12&#8239;hours, then 5000&#8239;units every 24&#8239;hours, alternatively initially 5000&#8239;units for 1 dose, dose to be given on the evening before surgery, followed by 5000&#8239;units after 24&#8239;hours, then 5000&#8239;units every 24&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of deep-vein thrombosis in medical patients",
                        "html": "Prophylaxis of deep-vein thrombosis in medical patients"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "5000 units every 24 hours.",
                        "html": "<p>5000&#8239;units every 24&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of deep-vein thrombosis, with oral anticoagulant treatment",
                        "html": "Treatment of deep-vein thrombosis, with oral anticoagulant treatment"
                    },
                    {
                        "textContent": "Treatment of pulmonary embolism, with oral anticoagulant treatment",
                        "html": "Treatment of pulmonary embolism, with oral anticoagulant treatment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "7500 units daily until adequate oral anticoagulation established.",
                        "html": "<p>7500&#8239;units daily until adequate oral anticoagulation established.</p>",
                        "ageGroup": "(body-weight up to 45 kg)"
                    },
                    {
                        "textContent": "10 000 units daily until adequate oral anticoagulation established.",
                        "html": "<p>10&#8239;000&#8239;units daily until adequate oral anticoagulation established.</p>",
                        "ageGroup": "(body-weight 46&#8211;56 kg)"
                    },
                    {
                        "textContent": "12 500 units daily until adequate oral anticoagulation established.",
                        "html": "<p>12&#8239;500&#8239;units daily until adequate oral anticoagulation established.</p>",
                        "ageGroup": "(body-weight 57&#8211;68 kg)"
                    },
                    {
                        "textContent": "15 000 units daily until adequate oral anticoagulation established.",
                        "html": "<p>15&#8239;000&#8239;units daily until adequate oral anticoagulation established.</p>",
                        "ageGroup": "(body-weight 69&#8211;82 kg)"
                    },
                    {
                        "textContent": "18 000 units daily until adequate oral anticoagulation established.",
                        "html": "<p>18&#8239;000&#8239;units daily until adequate oral anticoagulation established.</p>",
                        "ageGroup": "(body-weight 83 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Extended treatment and prophylaxis of venous thromboembolism in patients with solid tumours",
                        "html": "Extended treatment and prophylaxis of venous thromboembolism in patients with solid tumours"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "7500 units once daily for 30 days, then 7500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.",
                        "html": "<p>7500&#8239;units once daily for 30 days, then 7500&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>",
                        "ageGroup": "(body-weight 40&#8211;45 kg)"
                    },
                    {
                        "textContent": "10 000 units once daily for 30 days, then 7500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.",
                        "html": "<p>10&#8239;000&#8239;units once daily for 30 days, then 7500&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>",
                        "ageGroup": "(body-weight 46&#8211;56 kg)"
                    },
                    {
                        "textContent": "12 500 units once daily for 30 days, then 10 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.",
                        "html": "<p>12&#8239;500&#8239;units once daily for 30 days, then 10&#8239;000&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>",
                        "ageGroup": "(body-weight 57&#8211;68 kg)"
                    },
                    {
                        "textContent": "15 000 units once daily for 30 days, then 12 500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.",
                        "html": "<p>15&#8239;000&#8239;units once daily for 30 days, then 12&#8239;500&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>",
                        "ageGroup": "(body-weight 69&#8211;82 kg)"
                    },
                    {
                        "textContent": "18 000 units once daily for 30 days, then 15 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.",
                        "html": "<p>18&#8239;000&#8239;units once daily for 30 days, then 15&#8239;000&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>",
                        "ageGroup": "(body-weight 83&#8211;98 kg)"
                    },
                    {
                        "textContent": "18 000 units once daily for 30 days, then 18 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.",
                        "html": "<p>18&#8239;000&#8239;units once daily for 30 days, then 18&#8239;000&#8239;units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia&#8212;consult product literature.</p>",
                        "ageGroup": "(body-weight 99 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of venous thromboembolism in pregnancy",
                        "html": "Treatment of venous thromboembolism in pregnancy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "5000 units twice daily, use body-weight in early pregnancy to calculate the dose.",
                        "html": "<p>5000&#8239;units twice daily, use body-weight in early pregnancy to calculate the dose.</p>",
                        "ageGroup": "(body-weight up to 49 kg)"
                    },
                    {
                        "textContent": "6000 units twice daily, use body-weight in early pregnancy to calculate the dose.",
                        "html": "<p>6000&#8239;units twice daily, use body-weight in early pregnancy to calculate the dose.</p>",
                        "ageGroup": "(body-weight 50&#8211;69 kg)"
                    },
                    {
                        "textContent": "8000 units twice daily, use body-weight in early pregnancy to calculate the dose.",
                        "html": "<p>8000&#8239;units twice daily, use body-weight in early pregnancy to calculate the dose.</p>",
                        "ageGroup": "(body-weight 70&#8211;89 kg)"
                    },
                    {
                        "textContent": "10 000 units twice daily, use body-weight in early pregnancy to calculate the dose.",
                        "html": "<p>10&#8239;000&#8239;units twice daily, use body-weight in early pregnancy to calculate the dose.</p>",
                        "ageGroup": "(body-weight 90 kg and above)"
                    }
                ]
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}